Immunovant, Inc. - Common Stock (NQ:IMVT)Price and VolumeDetailed Quote
Top NewsMore News
Top movers in Wednesday's session ↗
May 20, 2026
Via Chartmill
Performance
More NewsRead More
Via Benzinga
Immunovant Q4 Earnings Call Highlights ↗
May 20, 2026
Via MarketBeat
Topics
Earnings
Via The Motley Fool
Topics
Government
Immunovant (IMVT) Q2 2025 Earnings Call Transcript ↗
February 06, 2026
Via The Motley Fool
Topics
Earnings
Roivant Sciences (ROIV): Anatomy of a 15% Surge and the Future of the ‘Vant’ Model
February 06, 2026
Via Finterra
Is Immunovant Stock a Buy After Roivant Sciences Increased Its Stake by $350 Million? ↗
December 18, 2025
Via The Motley Fool
Topics
Regulatory Compliance
Frequently Asked QuestionsIs Immunovant, Inc. - Common Stock publicly traded?
Yes, Immunovant, Inc. - Common Stock is publicly traded.
What exchange does Immunovant, Inc. - Common Stock trade on?
Immunovant, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Immunovant, Inc. - Common Stock?
The ticker symbol for Immunovant, Inc. - Common Stock is IMVT on the Nasdaq Stock Market
What is the current price of Immunovant, Inc. - Common Stock?
The current price of Immunovant, Inc. - Common Stock is 34.13
When was Immunovant, Inc. - Common Stock last traded?
The last trade of Immunovant, Inc. - Common Stock was at 05/21/26 04:00 PM ET
What is the market capitalization of Immunovant, Inc. - Common Stock?
The market capitalization of Immunovant, Inc. - Common Stock is 3.92B
How many shares of Immunovant, Inc. - Common Stock are outstanding?
Immunovant, Inc. - Common Stock has 4B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes. By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
|
>